Subscribe to Newsletter

January 2015 Issue of The Medicine Maker

Register to download
Register here to download any issue of The Medicine Maker for FREE.
Receive content, products, events as well as relevant industry updates from The Medicine Maker and its sponsors.
Stay up to date with our other newsletters and sponsors information, tailored specifically to the fields you are interested in

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.

Articles featured in this issue

Business & Regulation Business Practice

Power to the People

| Charlotte Barker

Who are the top 100 most influential people in drug development and manufacturing today?

Manufacture Vaccines

Vaccination Innovation

| Stephanie Vine

Are vaccines set for a makeover? Two studies from researchers in Massachusetts demonstrate the new approaches that R&D scientists are taking.

Business & Regulation Standards & Regulation

Adapting to Adaptive Licensing

| Stephanie Vine

EMA’s pilot project continues. Is the future of regulation adaptive?

Manufacture Advanced Medicine

The 100,000 Genomes Project

| Stephanie Vine

An ambitious UK sequencing project aims to learn more about patients with cancer and rare diseases

Business & Regulation Business Practice

Disposal Dispute

| Stephanie Vine

Who should pay for the disposal of unused medicines? Legal tussles continue over ‘drug takeback’ law in Californian county.

Manufacture Advanced Medicine

The Eyes Have It

| Charlotte Barker

For the first time, stem cell therapy has been recommended for use in Europe

Business & Regulation Standards & Regulation

Rare Record

| Stephanie Vine

Is research into orphan diseases on the rise?

Manufacture Small Molecules

R&D in Orbit

| Stephanie Vine

Why we need research in space? We spoke with Cynthia Bouthot at the Center for the Advancement of Science in Space (CASIS) to find out.

Manufacture Standards & Regulation

Beyond Barcodes

| Christian Hay

Serialization will enable our industry to take up its rightful place in the ‘Internet of Things’.

Business & Regulation Business Practice

Embracing Disruptive Technology

| Keith Williams

Big pharma must be more agile if it wants to make the most of the revolutionary advances that will shape the next decade.

Manufacture Drug Delivery

Bright Idea, Dim Design

| Richard Fazackerley

What’s convenient for manufacturers does not always result in a product that’s best for patients.

Manufacture Small Molecules

The Rebirth of Manufacturing?

| Vikramaditya G. Yadav

In today’s aggressive, cost-cutting climate, the desire to switch from batch to continuous manufacturing is strong.

Manufacture Small Molecules

Metabolic Engineering 101

| Vikramaditya G. Yadav

Primers on the science of metabolic engineering.

Manufacture Quality & Compliance

How to Embed Excellence

| Thomas Friedli, Christian Mänder, Nicolas Ponce

Having witnessed the evolution of operational excellence (OPEX), how do you implement it – and how do you ensure continued success?

Discovery & Development Formulation

Crystal Clear Predictions

| Christopher A. Hunter, Rafel Prohens

A new model for cocrystal formation could be a powerful tool for formulation scientists – no crystal structures required, it’s all about the surface contacts.

Business & Regulation Business Practice

Rediscovering Innovation

| Duncan Emerton

If pharma is to retain its reputation as an innovator, companies must be brave enough to explore new areas, new targets and new technologies.

Manufacture Business Practice

Engineering Success

Sitting Down With… Andy Skibo, Executive Vice President, Operations at MedImmune, and Chairman of the ISPE.


The Medicine Maker Power List 2015

Ranking the 100 most influential people in drug development and manufacture.

Discovery & Development Drug Delivery

The Bioavailability Toolbox

How can we overcome bioavailability challenges in our increasingly complex drug pipeline?

Discovery & Development

Aptar Pharma ‘Bag-on-Valve’

Aptar Pharma announces the re-launch of its Bag-on-Valve (BOV) activities in its Radolfzell manufacturing site

Other issues of 2015